JAK and signal transducer and activation of transcription (STAT) pathways mediate downstream effects of receptors for multiple chemokines and cytokines including IFN-I, making JAK-STAT signaling blockade an attractive approach in SLE [258]. The gene discussed is SOAT1; the disease is systemic lupus erythematosus.